LexaGene Holdings Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
LexaGene Holdings Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q1 2022 to Q4 2022.
  • LexaGene Holdings Inc. Retained Earnings (Accumulated Deficit) for the quarter ending November 30, 2022 was -$50.3M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 -$50.3M Nov 30, 2022 10-Q 2023-01-17
Q3 2022 -$48.3M Aug 31, 2022 10-Q 2022-10-18
Q1 2022 -$44.1M Feb 28, 2022 10-Q 2023-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.